World Class Speakers

The World Immunotherapy Congress agenda will feature 300+ speakers across multiple streams.

Speakers will come from the most successful, innovative and thought-provoking companies from around the world. They will be supported by leading suppliers from the mega tech companies to the latest start-ups who are shaking up the industry.

 

APPLY TO SPEAK

 

Meet our 2017 speakers

Dr Yasmina Abdiche, CSO, Wasatch Microfluidics

Dr Yasmina Abdiche at World Immunotherapy Congress

Dr Gregory P. Adams, Chief Development Officer, Eleven Biotherapeutics

Dr Gregory P. Adams at World Immunotherapy Congress

Dr Berthold Boedeker, Chief Scientist, Bayer Ag

Dr Berthold Boedeker at World Immunotherapy Congress

Dr Ezio Bonvini, Senior Vice President of Research, Macrogenics

Dr Ezio Bonvini at World Immunotherapy Congress

Dr Guillaume Brachet, PhD candidate, Université François-Rabelais de Tours

Dr Guillaume Brachet at World Immunotherapy Congress

Dr Renier Brentjens, Director, Cellular Therapeutics, Memorial Sloan-Kettering Cancer Center

Dr Renier Brentjens at World Immunotherapy Congress

Dr Patrick Burke, Associate Director, Seattle Genetics, Inc.

Dr Patrick Burke at World Immunotherapy Congress

Dr Richard Bystry, Senior Scientist, Asterand Bioscience

Dr Richard Bystry at World Immunotherapy Congress

Dr Nicolas Camper, Team Leader, Bioconjugation,, Abzena

Dr Nicolas Camper at World Immunotherapy Congress

Dr Kalidip Choudhury, VP, Business Development, XBiotech

Dr Kalidip Choudhury at World Immunotherapy Congress

Dr Jeannick Cizeau, Director of Research, Viventia Biotechnology Inc

Dr Jeannick Cizeau at World Immunotherapy Congress

Dr Davide Corti, Senior Vice President and Chief Scientific Officer, Humabs BioMed Sa

Dr Davide Corti at World Immunotherapy Congress

Dr Marc Damelin, Associate Director, Pfizer Worldwide Research & Development

Dr Marc Damelin at World Immunotherapy Congress

Dr Marc Damelin, Associate Director, Pfizer Worldwide Research & Development

Dr Marc Damelin at World Immunotherapy Congress

Dr Kangwen Deng, Senior Scientist, AbbVie

Dr Kangwen Deng at World Immunotherapy Congress

Dr Madiha Derouazi, Chief Executive Officer, Amal Therapeutics

Dr Madiha Derouazi at World Immunotherapy Congress

Dr Frank Detmers, Director of Ligand Application, Thermo Fisher Scientific Inc

Dr Frank Detmers at World Immunotherapy Congress

Dr Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office

Dr Helena Domingues at World Immunotherapy Congress

Dr Roman Drews, Senior Director Regulatory Affairs, LFB Biomanufacturing

Dr Roman Drews at World Immunotherapy Congress

Mr Etienne Drouet, Vice President of Strategic Development, Synteract H.C.R. Iberica Sl

Mr Etienne Drouet at World Immunotherapy Congress

Dr Philippe Duchateau, Chief Scientific Officer, Cellectis

Dr Philippe Duchateau at World Immunotherapy Congress

Professor Lindy Durrant, Joint CEO and CSO, Scancell Ltd

Professor Lindy Durrant at World Immunotherapy Congress

Dr David Edwards, Preclinical Scientist, Cancer Research UK

Dr David Edwards at World Immunotherapy Congress

Dr Diego Ellerman, Principal Scientific Researcher, Genentech

Dr Diego Ellerman at World Immunotherapy Congress

Gloria Esposito, CTO, Trianni Inc

Gloria Esposito at World Immunotherapy Congress

Dr Seth Ettenberg, Chief Scientific Officer, Unum Therapeutics Inc.

Dr Seth Ettenberg at World Immunotherapy Congress

Dr Seth Ettenberg, Chief Scientific Officer, Unum Therapeutics Inc.

Dr Seth Ettenberg at World Immunotherapy Congress

Dr Torben Frandsen, Vice President of Process Development, C.M.C. Biologics As

Dr Torben Frandsen at World Immunotherapy Congress

Dr JIm Freeth, Managing Director, Retrogenix

Dr JIm Freeth at World Immunotherapy Congress

Dr Annabelle Gerard, group Leader, HiFiBio SAS

Dr Annabelle Gerard at World Immunotherapy Congress

Dr Patricia Gräf, Associate Scientist Immunology R&D, Juno Therapeutics

Dr Patricia Gräf at World Immunotherapy Congress

Dr Ulf Grawunder, Chief Executive Officer & Founder, NBE Therapeutics

Dr Ulf Grawunder at World Immunotherapy Congress

Dr Olivier Heudi, Research Investigator, Novartis Ag

Dr Olivier Heudi at World Immunotherapy Congress

Ms Emma Hickman, Head of Target Validation, Immunocore Ltd

Ms Emma Hickman at World Immunotherapy Congress

Dr Marlon J. Hinner, Director of Immuno Oncology, Pieris Pharmaceuticals Gmbh

Dr Marlon J. Hinner at World Immunotherapy Congress

Dr Rebecca Houliston, Principle Scientist, Asterand Bioscience

Dr Rebecca Houliston at World Immunotherapy Congress

Dr Victoria Jennings, Post-doctoral Research Fellow, The Institute of Cancer Research, London

Dr Victoria Jennings at World Immunotherapy Congress

Dr Haiyan Jiang, Principal Scientist Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Companies

Dr Haiyan Jiang at World Immunotherapy Congress

Dr Soheila Josserand, Research Associate, NovImmune

Dr Soheila Josserand at World Immunotherapy Congress

Dr Meelis Kadaja, Director of Business Development, Icosagen Cell Factory Ltd

Dr Meelis Kadaja at World Immunotherapy Congress

Dr Surinder Kaur, Associate Director/Senior Scientist, Genentech

Dr Surinder Kaur at World Immunotherapy Congress

Dr Elizabeth Kingsley, Consultant, Retrogenix

Dr Elizabeth Kingsley at World Immunotherapy Congress

Dr Christian Klein, Head Oncology Programs, Roche Pharmaceutical Research and Early Development

Dr Christian Klein at World Immunotherapy Congress

Christian Kleusch, Application Specialist, NanoTemper

Christian Kleusch at World Immunotherapy Congress

Dr Matthias Klinger, Principal Scientist, Amgen Research Munich Gmbh

Dr Matthias Klinger at World Immunotherapy Congress

Dr Jiri Kovarik, Research Investigator, N.I.B.R.

Dr Jiri Kovarik at World Immunotherapy Congress

Dr John Lambert, Executive Vice President & Distinguished Research Fellow, Immunogen, Inc.

Dr John Lambert at World Immunotherapy Congress

Dr Ignace Lasters, CTO, Complix Nv

Dr Ignace Lasters at World Immunotherapy Congress

Dr Aurelien Lathuilière, Neurologist neuroscientist, Geneva University Hospital

Dr Aurelien Lathuilière at World Immunotherapy Congress

Dr Steven Lee, Senior Research Fellow, Institute of Immunology and Immunotherapy, University of Birmingham

Dr Steven Lee at World Immunotherapy Congress

Mr Colin Love, Chief Operating Officer, Replimune

Mr Colin Love at World Immunotherapy Congress

Dr Nicolas Mach, Chief Scientific Officer, MaxiVax

Dr Nicolas Mach at World Immunotherapy Congress

Dr Jean-FrançoisJean-Francois Mayol, Principal Investigator, Amal Therapeutics

Dr Jean-FrançoisJean-Francois Mayol at World Immunotherapy Congress

Dr Christoph Merten, Group Leader and Principal Investigator Genome Biology Unit, European Molecular Biology Laboratory

Dr Christoph Merten at World Immunotherapy Congress

Dr Dafne Mueller, Group Leader, Institute of Cell Culture and Immunotherapy, University of Stuttgart

Dr Dafne Mueller at World Immunotherapy Congress

Prof Dr Dario Neri, Co-founder, Philogen; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich

Prof Dr Dario Neri at World Immunotherapy Congress

Dr Stefan Nierkens, Principal Investigator Boelens/Nierkens Research Group & Head U-DAIR, UMC Utrecht

Dr Stefan Nierkens at World Immunotherapy Congress

Dr Ahuva Nissim, Reader, William Harvey Research Institute

Dr Ahuva Nissim at World Immunotherapy Congress

Professor Hardev Pandha, Professor of Medical Oncology, University of Surrey

Professor Hardev Pandha at World Immunotherapy Congress

Dr Anne Poupon, CNRS/INRA, University of Tours

Dr Anne Poupon at World Immunotherapy Congress

Dr Sonia Quaratino, Global Clinical Program Leader, Novartis Institutes For BioMedical Research

Dr Sonia Quaratino at World Immunotherapy Congress

Dr David Rabuka, Head of Research and Development, Catalent Pharma Solutions

Dr David Rabuka at World Immunotherapy Congress

Dr Erich Rajkovic, Head of Research Operations & Intellectual Property, Affimed GmbH

Dr Erich Rajkovic at World Immunotherapy Congress

Dr Janice Reichert, Executive Director, The Antibody Society

Dr Janice Reichert at World Immunotherapy Congress

Dr Catherine Sabatos-Peyton, Senior Investigator II, Immuno-oncology, Novartis

Dr Catherine Sabatos-Peyton at World Immunotherapy Congress

Dr Thomas Sandal, VP R&D, Crescendo Biologics Ltd

Dr Thomas Sandal at World Immunotherapy Congress

Dr Fay Saunders, Head of Mammalian Cell Culture (R&D), Fujifilm Diosynth Biotechnologies

Dr Fay Saunders at World Immunotherapy Congress

Dr Volker Schellenberger, Chief Executive Officer & President, Amunix Inc

Dr Volker Schellenberger at World Immunotherapy Congress

Dr Volker Schellenberger, Chief Executive Officer & President, Amunix Inc

Dr Volker Schellenberger at World Immunotherapy Congress

Dr Joern Schmitz, Department Head, Fraunhofer I.M.E.

Dr Joern Schmitz at World Immunotherapy Congress

Dr Abhinav Shukla, Sr. VP, Process Development and Manufacturing, KBI Biopharma

Dr Abhinav Shukla at World Immunotherapy Congress

Dr Oliver Spadiut, Group Leader of Integrated Bioprocess Development, Vienna University of Technology

Dr Oliver Spadiut at World Immunotherapy Congress

Dr Ryan Stafford, Director, Protein Engineering - Discovery, Sutro Biopharma Inc

Dr Ryan Stafford at World Immunotherapy Congress

Dr Michael Streit, Sr Director Clinical Research Lead, Janssen

Dr Michael Streit at World Immunotherapy Congress

Dr Meggy Suarez-Carmona, Postdoctoral Fellow, National Centre for Tumor Diseases, Heidelberg

Dr Meggy Suarez-Carmona at World Immunotherapy Congress

Dr Eduard Urich, Pre-Clinical Project Leader, Roche Innovation Center Basel

Dr Eduard Urich at World Immunotherapy Congress

Dr Wouter Verdurmen, Researcher, Department of Biochemistry, Radboud University Medical Center

Dr Wouter Verdurmen at World Immunotherapy Congress

Mr Alain Vertes, Managing Director, NxR Biotechnologies

Mr Alain Vertes at World Immunotherapy Congress

Dr Lorenz Waldmeier, Scientist, NBE-Therapeutics

Dr Lorenz Waldmeier at World Immunotherapy Congress

Dr Frank Walsh, Chief Executive Officer, Ossianix, Inc.

Dr Frank Walsh at World Immunotherapy Congress

Professor Herve Watier, Co-Ordinator of the MAbImprove LabEx, University of Tours

Professor Herve Watier at World Immunotherapy Congress

Dr Nancy Whiting, Vice President, Head of Medical Affairs, Seattle Genetics Inc

Dr Nancy Whiting at World Immunotherapy Congress

Dr Robert Wilkinson, Director of Oncology Research, MedImmune

Dr Robert Wilkinson at World Immunotherapy Congress

Dr Ulrich Wuellner, Associate Director of Discovery Research, Covagen AG

Dr Ulrich Wuellner at World Immunotherapy Congress

Dr Nicholas Yoder, Senior Scientist, Immunogen, Inc.

Dr Nicholas Yoder at World Immunotherapy Congress

Dr Eugene Zhukovsky, CSO, BIOMUNEX PHARMACEUTICALS

Dr Eugene Zhukovsky at World Immunotherapy Congress

 

Co-located with 

Part of


World Immunotherapy Congress 29-31 October, Basel, Switzerland

Part of the  Festival of Biologics

Sign Up for Event Updates